11:47 AM EST - Theralase Technologies Inc. : Has signed a Clinical Research Agreement with Princess Margaret Cancer Centre, University Health Network to conduct a Phase Ib clinical study for the indication of Non-Muscle Invasive Bladder Cancer. Theralase Technologies Inc.
shares V.TLT are trading down $0.02 at $0.35.
